One-Year Outcome After Endovascular Thrombectomy for Basilar Artery Occlusion With Mild Deficits

医学 基底动脉 冲程(发动机) 血管内治疗 闭塞 外科 动脉瘤 机械工程 工程类
作者
Yingjie Xu,Lulu Xiao,Pan Zhang,Weiliang Shi,Shidong Tan,Miaomiao Hu,Zandong Li,Xuelin Zhang,Wanqiu Zhang,Wuwei Chu,Lei Wang,Shuai Zhang,Shengfei Qin,Guanglin Luo,Hongguang Pan,Xiangxiang Chen,Jie Wen,Hao Chen,Xinfeng Liu,Wen Sun
出处
期刊:Stroke [Lippincott Williams & Wilkins]
卷期号:56 (8): 2122-2134 被引量:1
标识
DOI:10.1161/strokeaha.124.050389
摘要

BACKGROUND: The long-term benefits of endovascular thrombectomy (EVT) for basilar artery occlusion (BAO) in patients with low National Institutes of Health Stroke Scale scores upon admission remain unclear. This study aimed to compare the 1-year clinical follow-up outcomes of best medical management (BMM) alone versus BMM plus EVT. METHODS: Patients with BAO and admission National Institutes of Health Stroke Scale score of ≤10 at 65 stroke centers in China from December 2015 to June 2022 were retrospectively enrolled. The primary outcome was favorable functional outcome (a modified Rankin Scale score of 0–3 at 1 year). Early (door-to-puncture time ≤120 minutes) and late EVT (door-to-puncture time >120 minutes) classifications were defined as surrogates for comparing initial treatment with EVT versus late (potentially rescue) EVT after initially being treated with BMM only. Multivariable logistic regression and propensity score matching analyses were used to assess the association between treatment and outcomes. RESULTS: Among 1232 patients who had 1-year follow-up data, 856 (69.5%) were men, and the mean (SD) age was 65 (12) years. After adjustment for confounders, there were no significant differences between EVT and BMM in favorable functional outcome (odds ratio, 0.96 [95% CI, 0.71–1.29]; P =0.778). The cumulative 1-year mortality rate was 16.4% in the EVT group versus 13.7% in the BMM group (odds ratio, 1.23 [95% CI, 0.86–1.77]; P =0.262). Predefined subgroup analyses revealed that late EVT was inferior to early EVT (odds ratio, 0.47 [95% CI, 0.28–0.79]; P =0.005), while no significant difference was observed between BMM and early EVT in 1-year outcomes (odds ratio, 0.87 [95% CI, 0.63–1.21]; P =0.421). CONCLUSIONS: In this long-term follow-up study among patients with BAO admitted with a National Institutes of Health Stroke Scale score of ≤10, there were no significant differences in functional outcomes and mortality at 1 year between BMM plus EVT and BMM alone.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英俊的念寒完成签到,获得积分10
刚刚
秀丽的初柔完成签到,获得积分10
刚刚
刚刚
1秒前
1秒前
czx完成签到,获得积分10
1秒前
小红完成签到,获得积分10
1秒前
foceman完成签到,获得积分10
2秒前
he完成签到,获得积分10
2秒前
朴实海亦完成签到,获得积分10
2秒前
dsv完成签到,获得积分10
2秒前
Inter09完成签到,获得积分10
2秒前
cxl完成签到,获得积分10
3秒前
失眠呆呆鱼完成签到 ,获得积分10
3秒前
ff发布了新的文献求助10
3秒前
小柒柒完成签到,获得积分10
4秒前
liujianxin发布了新的文献求助10
4秒前
逢考必过完成签到,获得积分10
4秒前
西哥完成签到,获得积分10
4秒前
hhh2018687完成签到,获得积分10
4秒前
AR完成签到,获得积分10
5秒前
清澜庭完成签到,获得积分10
5秒前
shunlimaomi完成签到,获得积分10
5秒前
DADing发布了新的文献求助10
6秒前
000发布了新的文献求助30
6秒前
竹马子发布了新的文献求助10
6秒前
Morgans00完成签到,获得积分0
7秒前
K2L完成签到,获得积分10
7秒前
看不懂完成签到 ,获得积分10
7秒前
7秒前
Emily完成签到,获得积分10
7秒前
等月光完成签到,获得积分10
7秒前
7秒前
8秒前
情怀应助ff采纳,获得10
8秒前
研友_VZG7GZ应助liang2508采纳,获得10
8秒前
斯文败类应助liang2508采纳,获得10
8秒前
英姑应助liang2508采纳,获得10
8秒前
阳光总在风雨后完成签到,获得积分0
9秒前
思源应助liang2508采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Zeolites: From Fundamentals to Emerging Applications 1500
Encyclopedia of Materials: Plastics and Polymers 1000
Architectural Corrosion and Critical Infrastructure 1000
Early Devonian echinoderms from Victoria (Rhombifera, Blastoidea and Ophiocistioidea) 1000
Hidden Generalizations Phonological Opacity in Optimality Theory 1000
Handbook of Social and Emotional Learning, Second Edition 900
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4927230
求助须知:如何正确求助?哪些是违规求助? 4196614
关于积分的说明 13033700
捐赠科研通 3969366
什么是DOI,文献DOI怎么找? 2175324
邀请新用户注册赠送积分活动 1192409
关于科研通互助平台的介绍 1103081